703 related articles for article (PubMed ID: 28162975)
1. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.
Fishbein L; Leshchiner I; Walter V; Danilova L; Robertson AG; Johnson AR; Lichtenberg TM; Murray BA; Ghayee HK; Else T; Ling S; Jefferys SR; de Cubas AA; Wenz B; Korpershoek E; Amelio AL; Makowski L; Rathmell WK; Gimenez-Roqueplo AP; Giordano TJ; Asa SL; Tischler AS; ; Pacak K; Nathanson KL; Wilkerson MD
Cancer Cell; 2017 Feb; 31(2):181-193. PubMed ID: 28162975
[TBL] [Abstract][Full Text] [Related]
2. The genomic landscape of phaeochromocytoma.
Flynn A; Benn D; Clifton-Bligh R; Robinson B; Trainer AH; James P; Hogg A; Waldeck K; George J; Li J; Fox SB; Gill AJ; McArthur G; Hicks RJ; Tothill RW
J Pathol; 2015 May; 236(1):78-89. PubMed ID: 25545346
[TBL] [Abstract][Full Text] [Related]
3. Genetics of pheochromocytoma and paraganglioma.
Wachtel H; Fishbein L
Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):283-290. PubMed ID: 33764930
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.
de Cubas AA; Leandro-García LJ; Schiavi F; Mancikova V; Comino-Méndez I; Inglada-Pérez L; Perez-Martinez M; Ibarz N; Ximénez-Embún P; López-Jiménez E; Maliszewska A; Letón R; Gómez Graña A; Bernal C; Alvarez-Escolá C; Rodríguez-Antona C; Opocher G; Muñoz J; Megias D; Cascón A; Robledo M
Endocr Relat Cancer; 2013 Aug; 20(4):477-93. PubMed ID: 23660872
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
[TBL] [Abstract][Full Text] [Related]
6. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.
Comino-Méndez I; de Cubas AA; Bernal C; Álvarez-Escolá C; Sánchez-Malo C; Ramírez-Tortosa CL; Pedrinaci S; Rapizzi E; Ercolino T; Bernini G; Bacca A; Letón R; Pita G; Alonso MR; Leandro-García LJ; Gómez-Graña A; Inglada-Pérez L; Mancikova V; Rodríguez-Antona C; Mannelli M; Robledo M; Cascón A
Hum Mol Genet; 2013 Jun; 22(11):2169-76. PubMed ID: 23418310
[TBL] [Abstract][Full Text] [Related]
7. Malignancy in Pheochromocytoma or Paraganglioma: Integrative Analysis of 176 Cases in TCGA.
Suh YJ; Choe JY; Park HJ
Endocr Pathol; 2017 Jun; 28(2):159-164. PubMed ID: 28386672
[TBL] [Abstract][Full Text] [Related]
8. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
Gimenez-Roqueplo AP; Dahia PL; Robledo M
Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
[TBL] [Abstract][Full Text] [Related]
9. The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated Paragangliomas.
Oudijk L; Papathomas T; de Krijger R; Korpershoek E; Gimenez-Roqueplo AP; Favier J; Canu L; Mannelli M; Rapa I; Currás-Freixes M; Robledo M; Smid M; Papotti M; Volante M
Neuroendocrinology; 2017; 105(4):384-393. PubMed ID: 28122379
[TBL] [Abstract][Full Text] [Related]
10. Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor Progression.
Alzofon N; Koc K; Panwell K; Pozdeyev N; Marshall CB; Albuja-Cruz M; Raeburn CD; Nathanson KL; Cohen DL; Wierman ME; Kiseljak-Vassiliades K; Fishbein L
Mol Cancer Res; 2021 Sep; 19(9):1476-1485. PubMed ID: 33986121
[TBL] [Abstract][Full Text] [Related]
11. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
[TBL] [Abstract][Full Text] [Related]
12. ATRX driver mutation in a composite malignant pheochromocytoma.
Comino-Méndez I; Tejera ÁM; Currás-Freixes M; Remacha L; Gonzalvo P; Tonda R; Letón R; Blasco MA; Robledo M; Cascón A
Cancer Genet; 2016 Jun; 209(6):272-7. PubMed ID: 27209355
[TBL] [Abstract][Full Text] [Related]
13. Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma.
Galan SR; Kann PH
Clin Endocrinol (Oxf); 2013 Feb; 78(2):165-75. PubMed ID: 23061808
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.
Castro-Vega LJ; Buffet A; De Cubas AA; Cascón A; Menara M; Khalifa E; Amar L; Azriel S; Bourdeau I; Chabre O; Currás-Freixes M; Franco-Vidal V; Guillaud-Bataille M; Simian C; Morin A; Letón R; Gómez-Graña A; Pollard PJ; Rustin P; Robledo M; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2014 May; 23(9):2440-6. PubMed ID: 24334767
[TBL] [Abstract][Full Text] [Related]
15. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
[TBL] [Abstract][Full Text] [Related]
16. Genomic Landscape of Pheochromocytoma and Paraganglioma.
Jochmanova I; Pacak K
Trends Cancer; 2018 Jan; 4(1):6-9. PubMed ID: 29413423
[TBL] [Abstract][Full Text] [Related]
17. Hereditary paraganglioma-pheochromocytoma syndromes associated with SDHD and RET mutations.
Choi Jdo W; Tucker KM; Lee TT; Chong GC
Head Neck; 2014 Oct; 36(10):E99-E102. PubMed ID: 24375508
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.
Fishbein L
Hematol Oncol Clin North Am; 2016 Feb; 30(1):135-50. PubMed ID: 26614373
[TBL] [Abstract][Full Text] [Related]
19. Rethinking pheochromocytomas and paragangliomas from a genomic perspective.
Castro-Vega LJ; Lepoutre-Lussey C; Gimenez-Roqueplo AP; Favier J
Oncogene; 2016 Mar; 35(9):1080-9. PubMed ID: 26028031
[TBL] [Abstract][Full Text] [Related]
20. Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma.
Flynn A; Dwight T; Harris J; Benn D; Zhou L; Hogg A; Catchpoole D; James P; Duncan EL; Trainer A; Gill AJ; Clifton-Bligh R; Hicks RJ; Tothill RW
J Clin Endocrinol Metab; 2016 Mar; 101(3):1034-43. PubMed ID: 26796762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
